Suzhou, China

Guowei Song

USPTO Granted Patents = 3 


Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Guowei Song: Innovator in Pharmaceutical Chemistry

Introduction

Guowei Song is a notable inventor based in Suzhou, China, recognized for his contributions to pharmaceutical chemistry. With two patents to his name, he has made significant strides in the development of novel compounds aimed at addressing critical health issues.

Latest Patents

One of Guowei Song's latest inventions is the patent for isotope-enriched 3-amino-1-propanesulfonic acid derivatives and their uses. This innovative work includes the provision of isotope-enriched compounds of a specific formula, which can be used to create pharmaceutically acceptable salts or esters. These compounds and their pharmaceutical compositions play a vital role in the prevention and treatment of amyloid-β related diseases, such as Alzheimer's disease.

Career Highlights

Guowei actively contributes to Risen (Suzhou) Pharma Tech Co., Ltd., where he applies his expertise in pharmaceutical development. His work in this company is pivotal in advancing therapeutic options for neurological disorders.

Collaborations

Throughout his career, Guowei has collaborated with esteemed colleagues, including Jiasheng Lu and Jiamin Gu. Together, they combine their expertise to foster innovation in the pharmaceutical field, reflecting a cohesive effort to enhance health care solutions.

Conclusion

In conclusion, Guowei Song stands out as an accomplished inventor in Suzhou, China, demonstrating his commitment to developing solutions for significant health challenges. His recent patent on isotope-enriched compounds marks a crucial advancement in the fight against Alzheimer's disease, and his collaborative efforts continue to inspire innovation in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…